000 01274 a2200373 4500
005 20250514224425.0
264 0 _c20050623
008 200506s 0 0 eng d
022 _a1756-1833
024 7 _a10.1136/bmj.38415.708634.F7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEvans, Josie M M
245 0 0 _aMetformin and reduced risk of cancer in diabetic patients.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cJun 2005
300 _a1304-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCase-Control Studies
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMetformin
_xtherapeutic use
650 0 4 _aNeoplasms
_xprevention & control
650 0 4 _aPilot Projects
650 0 4 _aRisk Factors
700 1 _aDonnelly, Louise A
700 1 _aEmslie-Smith, Alistair M
700 1 _aAlessi, Dario R
700 1 _aMorris, Andrew D
773 0 _tBMJ (Clinical research ed.)
_gvol. 330
_gno. 7503
_gp. 1304-5
856 4 0 _uhttps://doi.org/10.1136/bmj.38415.708634.F7
_zAvailable from publisher's website
999 _c15516510
_d15516510